Drug Shortage Report for ACT EXEMESTANE
Report ID | 133470 |
Drug Identification Number | 02390183 |
Brand name | ACT EXEMESTANE |
Common or Proper name | EXEMESTANE 25MG FC TAB |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | EXEMESTANE |
Strength(s) | 25MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 UD |
ATC code | L02BG |
ATC description | HORMONE ANTAGONISTS AND RELATED AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-02-03 |
Estimated end date | 2021-03-31 |
Actual end date | 2021-03-30 |
Shortage status | Resolved |
Updated date | 2021-04-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-02-05 | English | Compare |
v2 | 2021-02-05 | French | Compare |
v3 | 2021-02-25 | English | Compare |
v4 | 2021-02-25 | French | Compare |
v5 | 2021-04-01 | English | Compare |
v6 | 2021-04-01 | French | Compare |
Showing 1 to 6 of 6